Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
403 | 3529 | 26.1 | 67% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
482 | 3 | MULTIPLE MYELOMA//AMYLOIDOSIS//TRANSTHYRETIN | 23544 |
967 | 2 | AMYLOIDOSIS//TRANSTHYRETIN//AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS | 10681 |
403 | 1 | AMYLOIDOSIS//AL AMYLOIDOSIS//CARDIAC AMYLOIDOSIS | 3529 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | AMYLOIDOSIS | authKW | 2379722 | 23% | 34% | 810 |
2 | AL AMYLOIDOSIS | authKW | 1094662 | 5% | 72% | 175 |
3 | CARDIAC AMYLOIDOSIS | authKW | 722013 | 3% | 71% | 117 |
4 | AMYLOIDOMA | authKW | 457971 | 2% | 88% | 60 |
5 | PRIMARY AMYLOIDOSIS | authKW | 307562 | 2% | 67% | 53 |
6 | AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS | journal | 292910 | 5% | 21% | 163 |
7 | AMYLOID TREATMENT PROGRAM | address | 290721 | 2% | 61% | 55 |
8 | SYSTEMIC AMYLOIDOSIS | authKW | 264087 | 2% | 58% | 53 |
9 | AMYLOIDOSIS TREATMENT | address | 214271 | 1% | 52% | 48 |
10 | SECONDARY AMYLOIDOSIS | authKW | 175960 | 1% | 44% | 46 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Medicine, General & Internal | 7871 | 23% | 0% | 801 |
2 | Pathology | 5029 | 11% | 0% | 395 |
3 | Hematology | 2979 | 10% | 0% | 337 |
4 | Cardiac & Cardiovascular System | 2659 | 12% | 0% | 419 |
5 | Rheumatology | 1961 | 5% | 0% | 161 |
6 | Transplantation | 1395 | 5% | 0% | 159 |
7 | Urology & Nephrology | 982 | 6% | 0% | 197 |
8 | Medicine, Research & Experimental | 931 | 7% | 0% | 253 |
9 | Gastroenterology & Hepatology | 894 | 6% | 0% | 197 |
10 | Radiology, Nuclear Medicine & Medical Imaging | 812 | 7% | 0% | 250 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | AMYLOIDOSIS | 499559 | 3% | 51% | 114 |
2 | AMYLOID TREATMENT PROGRAM | 290721 | 2% | 61% | 55 |
3 | AMYLOIDOSIS TREATMENT | 214271 | 1% | 52% | 48 |
4 | CARDIAC AMYLOIDOSIS PROGRAM | 95823 | 0% | 92% | 12 |
5 | AMYLOID TREATMENT | 66443 | 0% | 59% | 13 |
6 | CARDIOL ANGIOL P MED | 56613 | 0% | 55% | 12 |
7 | AMYLOIDOSIS TREATMENT PROGRAM | 51905 | 0% | 100% | 6 |
8 | REG AMYLOID | 46132 | 0% | 67% | 8 |
9 | AMYLOIDOSIS ACUTE PHASE PROT | 40124 | 1% | 17% | 27 |
10 | DYSPROTEINEMIA CLIN | 34603 | 0% | 100% | 4 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS | 292910 | 5% | 21% | 163 |
2 | INTERNAL MEDICINE | 2516 | 1% | 1% | 49 |
3 | AMERICAN JOURNAL OF HEMATOLOGY | 2262 | 1% | 1% | 40 |
4 | REVUE DE MEDECINE INTERNE | 2196 | 1% | 1% | 32 |
5 | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 1896 | 0% | 2% | 13 |
6 | BLOOD | 1442 | 2% | 0% | 79 |
7 | AMYLOID-INTERNATIONAL JOURNAL OF EXPERIMENTAL AND CLINICAL INVESTIGATION | 1438 | 0% | 8% | 2 |
8 | ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE | 1371 | 1% | 0% | 36 |
9 | JACC-CARDIOVASCULAR IMAGING | 1344 | 0% | 1% | 12 |
10 | HUMAN PATHOLOGY | 1278 | 1% | 0% | 35 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | AMYLOIDOSIS | 2379722 | 23% | 34% | 810 | Search AMYLOIDOSIS | Search AMYLOIDOSIS |
2 | AL AMYLOIDOSIS | 1094662 | 5% | 72% | 175 | Search AL+AMYLOIDOSIS | Search AL+AMYLOIDOSIS |
3 | CARDIAC AMYLOIDOSIS | 722013 | 3% | 71% | 117 | Search CARDIAC+AMYLOIDOSIS | Search CARDIAC+AMYLOIDOSIS |
4 | AMYLOIDOMA | 457971 | 2% | 88% | 60 | Search AMYLOIDOMA | Search AMYLOIDOMA |
5 | PRIMARY AMYLOIDOSIS | 307562 | 2% | 67% | 53 | Search PRIMARY+AMYLOIDOSIS | Search PRIMARY+AMYLOIDOSIS |
6 | SYSTEMIC AMYLOIDOSIS | 264087 | 2% | 58% | 53 | Search SYSTEMIC+AMYLOIDOSIS | Search SYSTEMIC+AMYLOIDOSIS |
7 | SECONDARY AMYLOIDOSIS | 175960 | 1% | 44% | 46 | Search SECONDARY+AMYLOIDOSIS | Search SECONDARY+AMYLOIDOSIS |
8 | LOCALIZED AMYLOIDOSIS | 150134 | 1% | 64% | 27 | Search LOCALIZED+AMYLOIDOSIS | Search LOCALIZED+AMYLOIDOSIS |
9 | RENAL AMYLOIDOSIS | 143169 | 1% | 47% | 35 | Search RENAL+AMYLOIDOSIS | Search RENAL+AMYLOIDOSIS |
10 | AA AMYLOIDOSIS | 138567 | 1% | 32% | 50 | Search AA+AMYLOIDOSIS | Search AA+AMYLOIDOSIS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | DISPENZIERI, A , BUADI, F , KUMAR, SK , REEDER, CB , SHER, T , LACY, MQ , KYLE, RA , MIKHAEL, JR , ROY, V , LEUNG, N , ET AL (2015) TREATMENT OF IMMUNOGLOBULIN LIGHT CHAIN AMYLOIDOSIS: MAYO STRATIFICATION OF MYELOMA AND RISK-ADAPTED THERAPY (MSMART) CONSENSUS STATEMENT.MAYO CLINIC PROCEEDINGS. VOL. 90. ISSUE 8. P. 1054 -1081 | 149 | 87% | 6 |
2 | MUCHTAR, E , BUADI, FK , DISPENZIERI, A , GERTZ, MA , (2016) IMMUNOGLOBULIN LIGHT-CHAIN AMYLOIDOSIS: FROM BASICS TO NEW DEVELOPMENTS IN DIAGNOSIS, PROGNOSIS AND THERAPY.ACTA HAEMATOLOGICA. VOL. 135. ISSUE 3. P. 172 -190 | 130 | 90% | 2 |
3 | DISPENZIERI, A , GERTZ, MA , BUADI, F , (2012) WHAT DO I NEED TO KNOW ABOUT IMMUNOGLOBULIN LIGHT CHAIN (AL) AMYLOIDOSIS?.BLOOD REVIEWS. VOL. 26. ISSUE 4. P. 137 -154 | 141 | 88% | 38 |
4 | KASTRITIS, E , DIMOPOULOS, MA , (2016) RECENT ADVANCES IN THE MANAGEMENT OF AL AMYLOIDOSIS.BRITISH JOURNAL OF HAEMATOLOGY. VOL. 172. ISSUE 2. P. 170 -186 | 79 | 87% | 7 |
5 | PALLADINI, G , MERLINI, G , (2013) SYSTEMIC AMYLOIDOSES: WHAT AN INTERNIST SHOULD KNOW.EUROPEAN JOURNAL OF INTERNAL MEDICINE. VOL. 24. ISSUE 8. P. 729-739 | 136 | 74% | 8 |
6 | EBERT, EC , NAGAR, M , (2008) GASTROINTESTINAL MANIFESTATIONS OF AMYLOIDOSIS.AMERICAN JOURNAL OF GASTROENTEROLOGY. VOL. 103. ISSUE 3. P. 776-787 | 120 | 83% | 75 |
7 | GERTZ, M , (2016) IMMUNOGLOBULIN LIGHT CHAIN AMYLOIDOSIS: 2016 UPDATE ON DIAGNOSIS, PROGNOSIS, AND TREATMENT.AMERICAN JOURNAL OF HEMATOLOGY. VOL. 91. ISSUE 9. P. 947 -956 | 103 | 91% | 0 |
8 | WECHALEKAR, AD , GILLMORE, JD , HAWKINS, PN , (2016) SYSTEMIC AMYLOIDOSIS.LANCET. VOL. 387. ISSUE 10038. P. 2641 -2654 | 85 | 67% | 9 |
9 | GERTZ, MA , (2014) IMMUNOGLOBULIN LIGHT CHAIN AMYLOIDOSIS: 2014 UPDATE ON DIAGNOSIS, PROGNOSIS, AND TREATMENT.AMERICAN JOURNAL OF HEMATOLOGY. VOL. 89. ISSUE 12. P. 1133 -1140 | 88 | 90% | 20 |
10 | MERLINI, G , SELDIN, DC , GERTZ, MA , (2011) AMYLOIDOSIS: PATHOGENESIS AND NEW THERAPEUTIC OPTIONS.JOURNAL OF CLINICAL ONCOLOGY. VOL. 29. ISSUE 14. P. 1924-1933 | 76 | 92% | 111 |
Classes with closest relation at Level 1 |